ArticleJHEP reports : innovation in hepatology2021

Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases.

Arun J Sanyal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.